Estrogen signaling in the cardiovascular system

Area of Science:

• Cardiovascular Physiology
• Endocrinology
• Molecular Biology

Background:

• Estrogen receptors (ERs), specifically ERalpha and ERbeta, mediate estrogen's diverse biological effects.
• Estrogen-activated ERs influence cardiovascular physiology through gene expression and rapid signaling pathways.
• 17-beta-estradiol (E2) generally exhibits protective effects on the vasculature.

Purpose of the Study:

• To elucidate the multifaceted roles of estrogen-activated ERs in cardiovascular health.
• To detail the mechanisms by which ERs impact vascular function, myocardial hypertrophy, and ischemic injury.

Main Methods:

• Review of existing literature on estrogen receptor signaling in the cardiovascular system.
• Analysis of studies investigating E2's effects on vascular function, atherogenesis, and cardiac protection.
• Examination of signaling pathways including PI3K/Akt, eNOS, and MAP kinases.

Main Results:

• E2 treatment is anti-atherogenic, reduces LDL oxidation, and protects injured endothelium.
• E2 stimulates nitric oxide (NO) production, leading to vasodilation via PI3K/Akt/eNOS signaling.
• ERs modulate ion channels, mitigate arterial injury response, prevent hypertension, and exert antihypertrophic effects on the myocardium.
• E2/ER activation antagonizes angiotensin II-induced hypertrophy and provides antiapoptotic protection to cardiomyocytes during ischemia-reperfusion via PI3K and p38 MAP kinases.

Conclusions:

• Estrogen-activated ERs positively modulate multiple cardiovascular functions.
• ER signaling pathways are crucial for maintaining vascular integrity, cardiac health, and protection against ischemic damage.
• Targeting ER pathways represents a potential therapeutic strategy for cardiovascular diseases.